首页|Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

扫码查看
The outbreak of COVID-19 has drawn great attention around the world.SARS-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation period.In particular,the emer-gence of asymptomatic infections has made the epidemic even more severe.Therefore,early diagnosis and timely management of suspected cases are essential measures to control the spread of the virus.Developing simple,portable,and accurate diagnostic techniques for SARS-CoV-2 is the key to epidemic prevention.The advantages of point-of-care testing technology make it play an increasingly important role in viral detection and screening.This review summarizes the point-of-care testing platforms devel-oped by nucleic acid detection,immunological detection,and nanomaterial-based biosensors detection.Furthermore,this paper provides a prospect for designing future highly accurate,cheap,and convenient SARS-CoV-2 diagnostic technology.

COVID-19Point-of-care testing platformsNucleic acid detectionAsymptomatic infectionBiosensors

Ya-Nan Tang、Dingding Jiang、Xuejun Wang、Yunqi Liu、Dacheng Wei

展开 >

State Key Laboratory of Molecular Engineering of Polymers,Department of Macromolecular Science,Fudan University,Shanghai 200433,China

Institute of Molecular Materials and Devices,Fudan University,Shanghai 200433,China

国家重点研发计划中国科学院战略规划重点项目国家自然科学基金Chongqing Bayu Scholar ProgramProgram of Shanghai Academic Research Leaders复旦大学项目

2021YFC2301100XDB3000000061890940DP202003623XD1420200

2024

中国化学快报(英文版)
中国化学会

中国化学快报(英文版)

CSTPCD
影响因子:0.771
ISSN:1001-8417
年,卷(期):2024.35(3)
  • 145